Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
Chung, Hyun Cheol, Bang, Yung-Jue, S Fuchs, Charles, Qin, Shu-Kui, Satoh, Taroh, Shitara, Kohei, Tabernero, Josep, Van Cutsem, Eric, Alsina, Maria, Cao, Zhu Alexander, Lu, Jia, Bhagia, Pooja, Shih, Chie-Schin, Janjigian, Yelena Y
Published in Future oncology (London, England) (01.02.2021)
Published in Future oncology (London, England) (01.02.2021)
Get full text
Journal Article
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
Hack, Stephen P, Spahn, Jessica, Chen, Minshan, Cheng, Ann-Lii, Kaseb, Ahmed, Kudo, Masatoshi, Lee, Han Chu, Yopp, Adam, Chow, Pierce, Qin, Shukui
Published in Future oncology (London, England) (01.05.2020)
Published in Future oncology (London, England) (01.05.2020)
Get full text
Journal Article
An overview of meningiomas
Buerki, Robin A, Horbinski, Craig M, Kruser, Timothy, Horowitz, Peleg M, James, Charles David, Lukas, Rimas V
Published in Future oncology (London, England) (01.09.2018)
Published in Future oncology (London, England) (01.09.2018)
Get full text
Journal Article
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
Janjigian, Yelena Y, Van Cutsem, Eric, Muro, Kei, Wainberg, Zev, Al-Batran, Salah-Eddin, Hyung, Woo Jin, Molena, Daniela, Marcovitz, Michelle, Ruscica, Dario, Robbins, Scott H, Negro, Alejandra, Tabernero, Josep
Published in Future oncology (London, England) (01.06.2022)
Published in Future oncology (London, England) (01.06.2022)
Get full text
Journal Article
Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA
Tsuboi, Masahiro, Weder, Walter, Escriu, Carles, Blakely, Collin, He, Jianxing, Dacic, Sanja, Yatabe, Yasushi, Zeng, Lingmin, Walding, Andrew, Chaft, Jamie E
Published in Future oncology (London, England) (01.11.2021)
Published in Future oncology (London, England) (01.11.2021)
Get full text
Journal Article
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
Mollica, Veronica, Rizzo, Alessandro, Massari, Francesco
Published in Future oncology (London, England) (01.09.2020)
Published in Future oncology (London, England) (01.09.2020)
Get full text
Journal Article
Systemic therapy of advanced hepatocellular carcinoma
Galle, Peter R, Dufour, Jean-François, Peck-Radosavljevic, Markus, Trojan, Jörg, Vogel, Arndt
Published in Future oncology (London, England) (01.04.2021)
Published in Future oncology (London, England) (01.04.2021)
Get full text
Journal Article
Chemotherapy-induced damage to ovary: mechanisms and clinical impact
Bedoschi, Giuliano, Navarro, Paula Andrea, Oktay, Kutluk
Published in Future oncology (London, England) (01.10.2016)
Published in Future oncology (London, England) (01.10.2016)
Get full text
Journal Article
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
Cho, Byoung Chul, Felip, Enriqueta, Hayashi, Hidetoshi, Thomas, Michael, Lu, Shun, Besse, Benjamin, Sun, Tao, Martinez, Melissa, Sethi, Seema N, Shreeve, S Martin, Spira, Alexander I
Published in Future oncology (London, England) (01.02.2022)
Published in Future oncology (London, England) (01.02.2022)
Get full text
Journal Article
Novel insights and therapeutic interventions for pediatric osteosarcoma
Kager, Leo, Tamamyan, Gevorg, Bielack, Stefan
Published in Future oncology (London, England) (01.02.2017)
Published in Future oncology (London, England) (01.02.2017)
Get full text
Journal Article
Pancreatic cancer: yesterday, today and tomorrow
Ansari, Daniel, Tingstedt, Bobby, Andersson, Bodil, Holmquist, Fredrik, Sturesson, Christian, Williamsson, Caroline, Sasor, Agata, Borg, David, Bauden, Monika, Andersson, Roland
Published in Future oncology (London, England) (01.08.2016)
Published in Future oncology (London, England) (01.08.2016)
Get full text
Journal Article
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Qin, Shukui, Finn, Richard S, Kudo, Masatoshi, Meyer, Tim, Vogel, Arndt, Ducreux, Michel, Macarulla, Teresa Mercade, Tomasello, Gianluca, Boisserie, Frederic, Hou, Jeannie, Li, Xin, Song, James, Zhu, Andrew X
Published in Future oncology (London, England) (01.06.2019)
Published in Future oncology (London, England) (01.06.2019)
Get full text
Journal Article
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1 -mutant breast cancer during first-line treatment
Turner, Nicholas, Huang-Bartlett, Cynthia, Kalinsky, Kevin, Cristofanilli, Massimo, Bianchini, Giampaolo, Chia, Stephen, Iwata, Hiroji, Janni, Wolfgang, Ma, Cynthia X, Mayer, Erica L, Park, Yeon Hee, Fox, Steven, Liu, Xiaochun, McClain, Sasha, Bidard, Francois-Clement
Published in Future Oncology (01.03.2023)
Published in Future Oncology (01.03.2023)
Get full text
Journal Article
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
Bekaii-Saab, Tanios S, Valle, Juan W, Van Cutsem, Eric, Rimassa, Lorenza, Furuse, Junji, Ioka, Tatsuya, Melisi, Davide, Macarulla, Teresa, Bridgewater, John, Wasan, Harpreet, Borad, Mitesh J, Abou-Alfa, Ghassan K, Jiang, Ping, Lihou, Christine F, Zhen, Huiling, Asatiani, Ekaterine, Féliz, Luis, Vogel, Arndt
Published in Future oncology (London, England) (01.10.2020)
Published in Future oncology (London, England) (01.10.2020)
Get full text
Journal Article
MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
Catenacci, Daniel V T, Rosales, Minori, Chung, Hyun Cheol, Yoon, Harry H, Shen, Lin, Moehler, Markus, Kang, Yoon-Koo
Published in Future oncology (London, England) (01.04.2021)
Published in Future oncology (London, England) (01.04.2021)
Get full text
Journal Article
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
Bang, Yung-Jue, Van Cutsem, Eric, Fuchs, Charles S, Ohtsu, Atsushi, Tabernero, Josep, Ilson, David H, Hyung, Woo Jin, Strong, Vivian E, Goetze, Thorsten Oliver, Yoshikawa, Takaki, Tang, Laura H, Hwang, Peggy May Tan, Webb, Nancy, Adelberg, David, Shitara, Kohei
Published in Future oncology (London, England) (01.03.2019)
Published in Future oncology (London, England) (01.03.2019)
Get full text
Journal Article
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2– breast cancer
Bardia, Aditya, Jhaveri, Komal, Kalinsky, Kevin, Pernas, Sonia, Tsurutani, Junji, Xu, Binghe, Hamilton, Erika, Im, Seock-Ah, Nowecki, Zbigniew, Sohn, Joohyuk, Laurentiis, Michelino De, Jañez, Noelia Martínez, Adamo, Barbara, Lee, Keun Seok, Jung, Kyung Hae, Rubovszky, Gábor, Tseng, Ling-Ming, Lu, Yen-Shen, Yuan, Yuan, Maxwell, Micah J, Haddad, Vincent, Khan, Sabrina S, Rugo, Hope S, Pistilli, Barbara
Published in Future oncology (London, England) (01.03.2024)
Published in Future oncology (London, England) (01.03.2024)
Get full text
Journal Article
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma
Shah, Manish A, Bennouna, Jaafar, Doi, Toshihiko, Shen, Lin, Kato, Ken, Adenis, Antoine, Mamon, Harvey J, Moehler, Markus, Fu, Xiaolong, Cho, Byoung Chul, Bordia, Sonal, Bhagia, Pooja, Shih, Chie-Schin, Desai, Anjali, Enzinger, Peter
Published in Future oncology (London, England) (01.04.2021)
Published in Future oncology (London, England) (01.04.2021)
Get full text
Journal Article
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer
Kato, Ken, Shah, Manish A, Enzinger, Peter, Bennouna, Jaafar, Shen, Lin, Adenis, Antoine, Sun, Jong-Mu, Cho, Byoung Chul, Özgüro lu, Mustafa, Kojima, Takashi, Kostorov, Vladimir, Hierro, Cinta, Zhu, Ying, McLean, Lee Anne, Shah, Sukrut, Doi, Toshihiko
Published in Future oncology (London, England) (01.04.2019)
Published in Future oncology (London, England) (01.04.2019)
Get full text
Journal Article